Overview
Neil Shah is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Familial Wilms Tumor 2, and Chromophobe Renal Cell Carcinoma. Dr. Shah is currently accepting new patients.
His clinical research consists of co-authoring 50 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1275 York Ave, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Memorial Solid Tumor Group
Darren Feldman is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy.
Memorial Solid Tumor Group
Robert Motzer is an Oncologist in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy.
Memorial Solid Tumor Group
Martin Voss is an Oncologist in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Renal Cell Carcinoma (RCC)
- Advanced
- Bladder CancerDr. Shah isAdvanced. Learn about Bladder Cancer.
- Chromophobe Renal Cell Carcinoma
- Clear Cell SarcomaDr. Shah isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Shah isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Cancer
- Experienced
- Adult Soft Tissue SarcomaDr. Shah isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Familial Prostate CancerDr. Shah isExperienced. Learn about Familial Prostate Cancer.
- Lung CancerDr. Shah isExperienced. Learn about Lung Cancer.
- Lung NodulesDr. Shah isExperienced. Learn about Lung Nodules.
- MelanomaDr. Shah isExperienced. Learn about Melanoma.
- Metastatic Brain TumorDr. Shah isExperienced. Learn about Metastatic Brain Tumor.